Collegium Pharmaceutical (COLL) Q1 2026 Earnings

26FebConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
1.43
1.71
1.98
2.25

Details

Expected EPS
2.13932
Actual EPS
2.04
Surprise EPS
-0.1
Surprise Percent
+4.64%

Description

Collegium Pharmaceutical (COLL) has reported earnings of 2.04 per share for Q1 2026.

0 Comments

Share your thoughts